Immuno-Cell Int. Company Profile

10:45 EDT 24th June 2018 | BioPortfolio

Immuno-Cell International © is specialized in the production of printed diagnostic slides and plates, for use in various types of diagnostic test kits. For the Diagnostic Industry (the manufactures of diagnostic test kits) we mostly manufacture these slides and cards custom-made (O.E.M. product). In addition we offer a wide range of standard items, which are available with low minimum order requirements. We supply our slides and cards to the leading test kits manufacturers. The secret of our success is due not only to our high quality product and the service that we povide, but also to the fact that we offer the most complete range of products in the field of diagnostic slides and cards


Hanswijk Ind.Park Motstraat 72/8


Phone: 32-15-43.31.88
Fax: 32-15-43.11.21

News Articles [1550 Associated News Articles listed on BioPortfolio]

Crown Bioscience enhances CAR-T cell therapy with bioluminescent imaging

CrownBio, a specialist in the field of preclinical immuno-oncology research, offers a chimeric antigen receptor T-cell platform for proof-of-concept and therapeutic efficacy validation

$1.6bn ARMO Buy Gives Lilly Its Most Advanced Immuno-Oncology Asset

Eli Lilly & Co. did not rush into the immuno-oncology game like its big pharma peers, but the acquisition of...   

Horizon licenses ‘copy and paste’ tech to optimise commercial cell line

Horizonâs gene editing technology will be used by a US immuno-oncology firm to make a cell line for commercial use.

10 Top Immuno-Oncology Companies

One of the most highly anticipated methods to fight cancer is the immuno-oncology (I/O) sector. For investors interested in the field the Investing News Network (INN) has put together a list of top im...

Horizon Discovery enters agreement with immuno-oncology company

Horizon Discovery Group, specialists in gene editing and gene modulation technologies, has entered into a non-exclusive out-licensing agreement with a US-based immuno-oncology therapeutics developer f...

Five Prime Therapeutics Triggers $5M Milestone

The first clinical candidate from the collaboration is a fully-human monoclonal antibody targeting TIM-3 , an immune checkpoint receptor that is known to limit the duration and magnitude of T-cell res...

Horizon Discovery out-licenses cell line engineering technology to US firm

Horizon Discovery Group has entered into a non-exclusive out-licensing agreement with an undisclosed US-based immuno-oncology company (the Partner) for its technologies to support the development and ...

New Scientific Advisors Focused on Cell Therapy in Immuno-Oncology and Autoimmunity Join Intellia Therapeutics

CAMBRIDGE, Mass., May 14, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technolo...

Drugs and Medications [19 Associated Drugs and Medications listed on BioPortfolio]

Sun care [Zenith Medicosm SL]

Drug Facts

Sun care [Zenith Medicosm SL]

Drug Facts

Alimta [Eli Lilly and Company]

These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA. ALIMTA (pemetrexed for injection) Lyophilized Powder, for ...

Hycamtin [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use HYCAMTIN safely and effectively. See full prescribing information for HYCAMTIN. HYCAMTIN (topotecan) CapsulesInitial U.S. Approval: 19...

Patanol [Physicians Total Care, Inc.]

PubMed Articles [2698 Associated PubMed Articles listed on BioPortfolio]

Development and Comparison of Two Immuno-disaggregation Based Bioassays for Cell Secretome Analysis.

Cell secretome analysis has gained increasing attention towards the development of effective strategies for disease treatment. Analysis of cell secretome enables the platform to monitor the status of ...

Inhibin-A and inhibin-B in cyclic and pregnant mares, and mares with granulosa-theca cell tumors: Physiological and diagnostic implications.

Studies in mares have examined serum inhibin concentrations using immuno-assays unable to distinguish dimeric inhibin-A from inhibin-B isoforms. Inhibin-A and inhibin-B immuno-assays were used to inve...

A microfluidic competitive immuno-aggregation assay for high sensitivity cell secretome detection.

We report a high-sensitivity cell secretome detection method using competitive immuno-aggregation and a micro-Coulter counter. A target cell secretome protein competes with anti-biotin-coated micropar...

Targeting the CD73-adenosine axis in immuno-oncology.

The ectonucleotidases CD39 and CD73 are cell surface enzymes that catabolize the breakdown of extracellular ATP into adenosine. As such, they constitute critical components of the extracellular purine...

Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.

Galectins (S-type lectins) are an evolutionarily-conserved family of lectin molecules, which can be expressed intracellularly and in the extracellular matrix, as well. Galectins bind β-galactose-cont...

Clinical Trials [6656 Associated Clinical Trials listed on BioPortfolio]

Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)

The purpose of this study is to find out what effects (good and bad) immunotherapy treatment using the p53 vaccine (Ad.p53-DC) in combination with Nivolumab and Ipilimumab has on small cel...

Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma

Multi-center, prospective randomised phase III study evaluating capecitabine in combination with standard-immunotherapy versus standard-immunotherapy alone as first-line therapy in patient...

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

This study includes the additional use of radiation therapy in combination immunotherapy in order to determine whether the radiation may improve the response of non-small cell lung cancer ...

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

The purpose of this study is to evaluate the safety and effectiveness of CAR-T cell immunotherapy in treating with GD2 positive glioma patients.

Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)

Autologous Tcm cells immunotherapy combining surgery or chemotherapy could effectively prolong survival period and improve quality of life in patients.

Companies [1024 Associated Companies listed on BioPortfolio]

Immuno-Cell Int.

Immuno-Cell International © is specialized in the production of printed diagnostic slides and plates, for use in various types of diagnostic test kits. For the Diagnostic Industry (the manufactures o...


Manufacture of slides and cards for use in test kits.

NantCell, Inc.

NantCell, an entity controlled by Dr. Patrick Soon-Shiong, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by de...

Immuno Diagnostic Oy

Immuno Diagnostic Oy was established in 1983. Thus, we have a long experience in importing and marketing high quality reagents for diagnostics and research. We provide our customers with a wide range ...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

More Information about "Immuno-Cell Int." on BioPortfolio

We have published hundreds of Immuno-Cell Int. news stories on BioPortfolio along with dozens of Immuno-Cell Int. Clinical Trials and PubMed Articles about Immuno-Cell Int. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immuno-Cell Int. Companies in our database. You can also find out about relevant Immuno-Cell Int. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record